U.K. Court Affirms Ruling Revoking Stent Patent

Law360, New York (January 16, 2007, 12:00 AM EST) -- In the latest development in a series of legal battles over the lucrative market for drug-eluting coronary stents, a U.K. court Tuesday dismissed an appeal of a lower court’s decision to revoke a patent owned by Angiotech Pharmaceuticals Inc. and licensed by Boston Scientific Corp.

The U.K. Court of Appeals’ decision affirmed a February 24, 2006 ruling by the Patents Court in the Chancery Division of the High Court of Justice, which granted plaintiff Conor Medsystems Inc. a win by finding that the U.K. portion of...
To view the full article, register now.